1354444-72-6
Chemical Structure
EA-B2L
- CAS No.: 1354444-72-6
- Formula:C35H54Cl2N4O8
- Molecular Weight:729.73
InChIKey: JCGCSVDVJPNMLG-VWLOTQADSA-N
SMILES: CCC(C(C1=C(C(Cl)=C(C=C1)OCC(NCCCCCCNC([C@H](CCCCNC(OC(C)(C)C)=O)NC(OC(C)(C)C)=O)=O)=O)Cl)=O)=C
Biological Activity: EA-B2L is a GSTP degrader with a DC50 of 48 μM in HeLa cells. EA-B2L inhibits GSTP enzymatic activity, induces dose-dependent GSTP degradation via the ubiquitin-proteasome and autophagy pathways, and does not activate the 20S proteasome subunit. EA-B2L induces dose-dependent apoptosis in cancer cells, a process associated with GSTP degradation, caspase 3 activation, and PARP cleavage. EA-B2L exerts dose-dependent antiproliferative effects on cancer cells with high GSTP expression. EA-B2L can be used in the research of cervical cancer, lung cancer, and fibrosarcoma[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
EA-B2L | EA-B2L is a GSTP degrader with a DC50 of 48 μM in HeLa cells. EA-B2L inhibits GSTP enzymatic activity, induces dose-dependent GSTP degradation via the ubiquitin-proteasome and autophagy pathways, and does not activate the 20S proteasome subunit. EA-B2L induces dose-dependent apoptosis in cancer cells, a process associated with GSTP degradation, caspase 3 activation, and PARP cleavage. EA-B2L exerts dose-dependent antiproliferative effects on cancer cells with high GSTP expression. EA-B2L can be used in the research of cervical cancer, lung cancer, and fibrosarcoma. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
